Fair Value Calculator Fair Value Calculator
EN DE

SUNILTX (SUNILTX) Fair Value & Analysis

IN · Market cap ₹363M

S SUNILTX SUNILTX · BSE
Price₹86.50
Fair Value₹219.09
Upside+153.3%
Quality64/100
Watch SUNILTX for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹164.32 – ₹273.86

Fair value as of: Jul 6, 2026

From 24 valuation models · updated today

Share price +8.4% over the past month.

Price vs Fair Value (12 months)

₹98.80 ₹59.50 Fair Value ₹219.09 Jul 2025 Jul 2026

12‑month range ₹59.50 – ₹98.80 · fair‑value band ₹164.32 – ₹273.86 · the ₹86.50 price screens below the ₹219.09 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

SUNILTX (SUNILTX) currently trades at ₹86.50, while our model-based Fair Value estimate is ₹219.09 — implying the stock looks roughly 153.3% undervalued today. We read business quality at 64/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, SUNILTX generated revenue of ₹2.3B at a net margin of 2.0%. Revenue grew 88.7% year over year. It earns a return on equity of 8.9%. Net debt stands at ₹343M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹164.32 (bear case) to ₹273.86 (bull case); at ₹86.50, the current price sits below that range. The share trades about 13% below its 52-week high and 45% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹2.3B
Revenue growth (YoY) +88.7%
Net margin 2.0%
Return on equity 8.9%
Free cash flow ₹173M FY2026
P/E ratio 7.9
More key figures
Operating margin 2.7%
EPS (TTM) ₹10.95
EPS growth (YoY) -47.3%
Net debt ₹343M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

SUNILTX reported revenue of ₹2.3B in FY2026 versus ₹1.6B in FY2022, a compound +8.8%/yr. Reported net income was ₹46.0M in FY2026, compounding +14.1%/yr from FY2022.

Revenue +8.8%/yr
FY22 ₹1.6B
FY23 ₹2.3B
FY24 ₹1.8B
FY25 ₹1.7B
FY26 ₹2.3B
Net income +14.1%/yr
FY22 ₹27.1M
FY23 ₹34.4M
FY24 ₹22.4M
FY25 ₹39.0M
FY26 ₹46.0M

Is SUNILTX fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "SUNILTX Fair Value". https://www.fairvalue-calculator.com/stock/SUNILTX

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is SUNILTX (SUNILTX) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹219.09 versus a price of ₹86.50 — about +153% (undervalued). Model-based estimate, not financial advice.
What is the fair value of SUNILTX?
Our model-based fair value for SUNILTX is ₹219.09 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹86.50.
What is the quality score of SUNILTX?
SUNILTX has a Quality Score of 64/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of SUNILTX (SUNILTX)?
SUNILTX reported trailing-twelve-month revenue of about ₹2.3B (latest available figure, as of Jul 6, 2026).
What is the net profit margin of SUNILTX?
The net profit margin of SUNILTX is about 2.0%, meaning it keeps roughly 2.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.